MedTrace Logo

Effects of Photobiomodulation in a Population Suffering From Fibromyalgia

NCT04248972 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2022-02-28

No results posted yet for this study

Summary

The development of an integral and global treatment to improve the quality of life in those with fibromyalgia syndrome (FMS) is challenging, thus a whole body Photobiomodulation (PBM) therapy program is proposed as an effective option.

Conditions

Interventions

DEVICE

PBM

A whole body red light therapy (NovoTHOR®) will be carried out during 20 minutes

OTHER

PLACEBO PBM

A placebo whole body red light will be carried out during 20 minutes

Sponsors & Collaborators

  • University of Malaga

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-30
Primary Completion
2021-07-30
Completion
2022-01-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04248972 on ClinicalTrials.gov